QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A10F0BAC488BB1596C5F0CE4F667FB3F;jsessionid=4604EAF85061B7D2112CE838C4F764A6;jsessionid=836309E9620C7A1CF5F46B6A49B3A9A9;jsessionid=A5EF37DC0D7A69FCEB3BBCDCBF7690B8;jsessionid=FAE3DE54D21DBB7F68F8AF7F29BE3F3A;jsessionid=DCC730263CCD72778A6D04297B3A3719 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A10F0BAC488BB1596C5F0CE4F667FB3F;jsessionid=4604EAF85061B7D2112CE838C4F764A6;jsessionid=836309E9620C7A1CF5F46B6A49B3A9A9;jsessionid=A5EF37DC0D7A69FCEB3BBCDCBF7690B8;jsessionid=FAE3DE54D21DBB7F68F8AF7F29BE3F3A;jsessionid=DCC730263CCD72778A6D04297B3A3719